Table 2.
nPOD donors subjected to WES.
| Clinical Group | Female | Male | Black/African American | American Indian/Alaska Native | Asian | White/Caucasian | Hispanic/Latinx | Multiracial | Age (Median [IQR]) | Diabetes Duration (Median [IQR]) |
|---|---|---|---|---|---|---|---|---|---|---|
| No Diabetes | 4 | 9 | 2 | 1 | 0 | 8 | 2 | 0 | 19.00 [7.8–24.5] | N/A |
| AAb+ | 12 | 22 | 5 | 0 | 0 | 21 | 8 | 0 | 25.17 [22.0–36.4] | N/A |
| T1D | 62 | 73 | 21 | 0 | 0 | 105 | 9 | 0 | 24.00 [17.5–32.6] | 10.00 [5.0–19.0] |
| Transplant | 0 | 6 | 0 | 0 | 0 | 4 | 2 | 0 | 42.34 [37.2–53.2] | 28.00 [20.0–36.0] |
| Gestational Diabetes | 4 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 33.35 [32.2–33.9] | 0.06 [0.1–0.1] |
| Monogenic Diabetes | 2 | 2 | 1 | 0 | 0 | 2 | 1 | 0 | 33.55 [24.6–41.7] | 17.50 [12.0–22.0] |
| Other-Diabetes | 5 | 6 | 2 | 0 | 0 | 7 | 2 | 0 | 34.00 [29.0–47.0] | 3.50 [1.5–14.2] |
| Total | 88 | 118 | 32 | 1 | 0 | 148 | 25 | 0 |
Data are presented as number of male and female donors and number of donors per reported race/ethnicity, along with age (years) and diabetes duration (years). AAb+ : islet autoantibody positive, T1D: Type 1 diabetes, N/A: not applicable, IQR: interquartile range.